Company: ZLAB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023411
Chunk: 31

Company: Zai Lab Ltd
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
, 2024978,197,710 6 2,993,282 (2,249,451)39,168 (4,912,200)(20,836)762,169 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. “0” in above table means less than 1,000 dollars. 

5

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Cash Flows 

(in thousands of $) 

Three Months EndedMarch 31,20252024Cash flows from operating activitiesNet loss(48,438)(53,471)Adjustments to reconcile net loss to net cash used in operating activities:  Allowance for credit losses(3)1 Inventory write-down27 37 Depreciation and amortization expenses3,458 3,012 Amortization of deferred income(1,331)(840)Share-based compensation15,800 17,980 Loss (gain) from fair value changes of equity investment with readily determinable fair value1,912 (4,889)Losses on disposal of property and equipment— 407 Noncash lease expenses2,466 2,069 Debt issuance costs— 700 Foreign currency remeasurement impact(651)2,068 Changes in operating assets and liabilities:  Accounts receivable8,737 (1,328)Notes receivable(6,885)(9,239)Inventories(13,198)6,818 Prepayments and other current assets(1,601)(1,253)Other non-current assets1,401 (271)Accounts payable2,720 (13,370)Other current liabilities(23,275)(34,204)Operating lease liabilities(2,827)(2,783)Deferred income(11)(1,550)Net cash used in operating activities(61,699)(90,106)Cash flows from investing activities  Proceeds from maturity of short-term investment330,000 16,300 Purchases of property and equipment(1,534)(974)Acquisition of intangible assets(2,333)(12,034)Net cash provided by investing activities326,133 3,292 Cash flows from financing activities  Proceeds from short-term debt101,890 48,248 Repayment of short-term bank borrowings (60,904)— Payments of debt issuance costs— (700